CHRNA4 and lung carcinoma: Kononenko et al. [124] examined a novel lung cancer treatment strategy using GNPs as carriers for APS7, which is a synthetic analog of a marine toxin that functions as a nicotinic acetylcholine receptor (nAChR) antagonist.